XKRX
002760
Market cap37mUSD
Jul 10, Last price
954.00KRW
1D
0.10%
1Q
-16.24%
Jan 2017
-17.47%
Name
Bolak Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bolak Company Limited, founded in 1959 and headquartered in Hwaseong-si, South Korea, is a global manufacturer and supplier of a wide array of specialized ingredients. Its comprehensive product range caters to various sectors, including food, pharmaceuticals, and cosmetics, serving both domestic and international markets. For the food industry, Bolak provides flavorings for confectionery, beverages, and dairy products, along with food colorants, gum bases, and sweeteners. The pharmaceutical division offers active pharmaceutical ingredients (APIs) such as dry, viscous, and fluid extracts, tinctures, natural paclitaxel, docetaxel trihydrates, and Ca-CMC. Additionally, the company develops functional ingredients for health supplements, including green tea, soy isoflavone, and ginseng extracts. Bolak also supplies numerous cosmetic ingredients, including fragrances designed for perfumes, various cosmetic formulations, hair care items, daily essentials, soaps, candles, and industrial applications. Beyond these, its portfolio extends to other diverse products such as surfactants, whitening agents, preservatives, antioxidants, abrasives, and thickening agents, alongside caffeine and baking powder.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||